BIOREGENX, INC. Quarterly Liabilities and Equity in USD from Q4 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Bioregenx, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2021 to Q2 2025.
  • Bioregenx, Inc. Liabilities and Equity for the quarter ending June 30, 2025 was $1.15M, a 93.6% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $1.15M -$16.7M -93.6% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $483K -$18.1M -97.4% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $509K -$357K -41.3% Dec 31, 2024 10-Q 2025-08-14
Q3 2024 $17.4M +$17.3M +50991% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $17.9M +$17.8M +20824% Jun 30, 2024 10-Q 2024-10-09
Q1 2024 $18.6M +$18.5M +23775% Mar 31, 2024 10-Q/A 2024-10-09
Q4 2023 $866K +$807K +1364% Dec 31, 2023 10-K/A 2025-04-16
Q3 2023 $34K Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $85.5K Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $78K Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $59.1K -$68.6K -53.7% Dec 31, 2022 10-K 2024-04-12
Q4 2021 $128K Dec 31, 2021 10-K 2023-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.